Feeling like you’re facing
cancer alone…

Meet the national network
fighting in your corner

Advocacy Groups

We’re a partner that can help you make a real difference for those affected by cancer.

How Omico is making a difference

video_icon

Omico works with patient advocacy groups to provide accelerated access to Comprehensive Genomic Profiling and new treatment options for individuals and families affected by difficult-to-treat, advanced and early-onset or rare cancers. We’re also working to transform tomorrow’s healthcare system.


Explore ways of working with us

Why work with Omico?

1

Make your trials cheaper and faster to run.

2

Get access to 25,000 screened patients.

3

Identify the right patients and the right trials.

4

Draw on the knowledge and expertise of our network.

Partnering with Omico

As a national, independent not-for-profit organisation, supported by government and private funding, Omico is working with government and industry to increase access for Australians to precision oncology screening tests and treatments, so we can match those with advanced, incurable or poor prognosis cancers to clinical trials of innovative new therapies.

We are looking to partner with advocacy groups to drive new hope and possibilities for Australians with cancer.

Our Progress

16,308 Patients Screened
849 Referring Clinicians
9,143 Patients with a treatment recommendation
1,506 Patients accessing a matched therapy

Ways of working with us

  • Help improve patient access to genomic screening and molecular profiling
  • Help bring new treatments to Australia
  • Support our research and trials
  • Support a particular cohort or subtrial
  • Provide support for patients and families
  • Advocate for ongoing funding and support
  • Co-promote our programs
  • And more

Our work

Finding new treatment paths for difficult-to-treat cancers

Omico’s landmark Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) aims to open up new options for patients with difficult-to-treat, advanced and metastatic cancers.

Matching patients to biomarker-led clinical trials

Through our Cancer Screening Project (CaSP) we’re performing comprehensive genomic profiling for cancer patients with unmet clinical need to match them to clinical trials or other care pathways.

Matching molecular changes to targeted therapy

Our Molecular Screening and Therapeutics (MoST) study aims to characterise molecular changes in a patient’s cancer that may help to identify a targeted therapy.

Identifying genetic basis of cancer risk

We’re examining the genetic basis of inherited cancer with our Genetic Cancer Risk in the Young (RisC) study.

Improving surveillance of multi-organ cancer

Our Surveillance study in Multi-Organ Cancer-prone syndromes (SMOC+) study is investigating and evaluating the surveillance practices used for people at high risk of multi-organ cancer.

Patient Advocacy Groups


Rare Cancers Australia
Rare Cancers Australia (RCA) provides support and advocacy for patients wishing to participate in Omico programs. If you or your family need advice or help, a place to learn or simply someone to listen, RCA can help.


Visit the RCA website

Canteen
If you are aged from 12 to 25 and your world has been turned upside down by cancer, Canteen provides support as well as someone to talk to.


Visit the Canteen website

Peace of Mind Foundation
Peace of Mind brings support, here and now and is the only organisation of its kind in Australia to help brain cancer patients with one on one personal support.


Visit the Peace of Mind Foundation

Providing personalised and specialised care to anyone in Australia facing the impacts of ovarian cancer.


Visit the Ovarian Cancer website

Cooper Rice-Brading Foundation (CRBF)
The aim of CRBF is to fund clinical research to find a cure for sarcoma, while raising awareness of sarcoma in the greater community in an effort to promote early diagnosis, and to provide support for sarcoma patients and their families.


Visit the CRBF website

Pancare Foundation
The Pancare Foundation are a leading charity committed to inspiring hope, raising awareness, supporting families and funding research for upper gastrointestinal (GI) cancers.


Visit the Pancare website

Australian Rare Cancer Portal
The Australian Rare Cancer (ARC) Portal is an online referral service that aims to improve outcomes and access to research for Australians diagnosed with rare cancer. Working together with your cancer specialist, the ARC Portal offers expert clinical advice, particularly for Australians who live far away from major metropolitan centres where cancer centres may not be available.


Visit the ARC Portal

Contact us to explore and discuss collaboration opportunities

Let’s work together